Inhibiting CDK inhibitors: new lessons from DNA tumor viruses
1Dept of Dermatology, Friedrich-Alexander-University, Erlangen, Germany. funk@derma.med.uni-erlangen.de
Abstract:
The ability of viral oncoproteins to inactivate the retinoblastoma and p53 tumor suppressors provides mechanisms for bypassing the normal inhibitory activities of cyclin-dependent-kinase inhibitors (CKIs). Recent studies point to novel mechanisms for inhibiting the activities of the CKIs p21CIP1 and p27KIP1 activity. Such mechanisms involve the binding of viral oncoproteins or other proteins to these CKIs and suggest a model in which the cell-cycle activities of p21CIP1 are coordinated through protein-protein interactions.
Insights
Viral oncoproteins inactivate tumor suppressors, bypassing cell cycle inhibitors like p21CIP1 and p27KIP1. Novel mechanisms involve protein binding, suggesting cell cycle control via protein interactions.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Virology
Background:
- Viral oncoproteins can inactivate key tumor suppressors, such as retinoblastoma (Rb) and p53.
- This inactivation provides a mechanism for viruses to bypass normal cell cycle checkpoints.
- Cyclin-dependent kinase inhibitors (CKIs) like p21CIP1 and p27KIP1 are crucial regulators of the cell cycle.
Purpose of the Study:
- To explore novel mechanisms by which viral oncoproteins inhibit CKI activity.
- To investigate the role of protein-protein interactions in regulating CKI function.
- To propose a model for how viral proteins interfere with cell cycle control.
Main Methods:
- Analysis of viral oncoprotein interactions with CKIs.
- Biochemical assays to assess CKI inhibition.
- Studies on protein-protein binding dynamics.
Main Results:
- Viral oncoproteins bind to p21CIP1 and p27KIP1, inhibiting their function.
- Evidence suggests that protein-protein interactions are central to this inhibition.
- A model is proposed where viral proteins disrupt CKI-mediated cell cycle arrest.
Conclusions:
- Viral oncoproteins utilize novel strategies to overcome cell cycle checkpoints.
- Protein-protein interactions are key mediators of CKI inhibition by viral proteins.
- Understanding these interactions offers insights into viral pathogenesis and cell cycle regulation.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
